filmov
tv
PGAP3-Congenital Disorder of Glycosylation

Показать описание
PGAP3-congenital disorder of glycosylation, or PGAP3-CDG for short, also known as Mabry syndrome and previously known as hyperphosphatasia with impaired intellectual development syndrome 4, is a rare inherited neurological disorder caused by defects in one of the pathways of glycosylation.
Affected individuals can have distinctive facial features that include a broad and short nose, wide-set eyes, a thin upper lip, large ears, and full cheeks; though these features may not be apparent in infancy.
#shorts
Follow us on social:
Our Vision: Everyone who cares for someone will learn by Osmosis.
© 2024 Elsevier. All rights reserved.
Affected individuals can have distinctive facial features that include a broad and short nose, wide-set eyes, a thin upper lip, large ears, and full cheeks; though these features may not be apparent in infancy.
#shorts
Follow us on social:
Our Vision: Everyone who cares for someone will learn by Osmosis.
© 2024 Elsevier. All rights reserved.
PGAP3-congenital disorder of glycosylation (Year of the Zebra)
PGAP3-Congenital Disorder of Glycosylation
Congenital disorders of glycosylation
Why It Is Difficult to Quickly Diagnose Congenital Disorders of Glycosylation
Congenital Disorders of Glycosylation
Frontiers in Congenital Disorders of Glycosylation Consortium (FCRGC)
CDRC 2021 Annual Meeting: Congenital disorders of glycosylation
Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function
The Past, Present and Future of Congenital Disorders of Glycosylation with Prof. Hudson Freeze
Mental Health Patient Insight Series: Louise and Pasq's Story of Life with ALG1 CDG
Introduction to CDG and FCDGC
What Is a Congenital Disorder of Glycosylation?
Congenital disorder of glycosylation (CDG): PMM2 pathogenesis #Code: 187
Nazarian Raising CDG Awareness
Therapeutic approaches against CDG (Congenital disorder of glycosylation) #Code: 279
Congenital disorder of glycosylation (Medical Condition)
Genetic Counseling for CDG - Carolyn Brown, MSc, CGC, CCGC
The Best of: Second World Conference on Congenital Disorders of Glycosylation (CDG), 2015 - (Lyon)
What is PIGA-CDG?
Glycosylation vs. Glycation
Therapy ideas against mannose related glycosylation defects (CDG) #Code: 281
Raising awareness of rare genetic disease CDG
Congenital disorder of glycosylation
ImmunoCDGQ - The Immunology and CDG Questionnaire for the entire CDG Community
Комментарии